Latest Leadership Change News

Wisr Limited has reported a standout Q4FY25 with loan originations soaring 154% year-on-year, surpassing its full-year guidance and showcasing improved credit quality.

Piche Resources has appointed Karilyn Farmer as Managing Director, signaling a strategic push for its gold and uranium assets as founder Stephen Mann retires.

Corazon Mining has completed the sale of its remaining interest in the Miriam Project, appointed Simon Coyle to its board, and continues to push exploration in Canada and Australia amid a strategic review.

Richmond Vanadium Technology has paused parts of its feasibility study and approval processes in response to a prolonged downturn in vanadium prices, focusing instead on metallurgical innovation and cash conservation.

Peninsula Energy advances commissioning at its Lance uranium project, resets most sales contracts to reduce risk, and secures a $15 million debt facility to support production ramp-up.

Arovella Therapeutics reported a robust $20.9 million cash position as it prepares for its first-in-human trial of ALA-101 and expands its solid tumour pipeline through new licensing agreements and leadership appointments.

Bubs Australia has appointed Joe Coote as its new CEO, bringing extensive international FMCG and dairy leadership to spearhead its global growth ambitions in infant nutrition.

Peninsula Energy has completed a major reset of its uranium offtake contracts, terminating five of six agreements with a $6.6 million payout, while advancing commissioning of its Central Processing Plant toward first yellowcake production in Q3 2025.

Adrad Holdings has appointed Paul Proctor as interim CEO following Kevin Boyle's resignation, while maintaining a steady earnings forecast for FY25.

ClearVue Technologies has appointed Douglas Hunt as its permanent Global CEO, unveiling a refreshed leadership team focused on scaling sales, manufacturing, and product innovation. The new executives have agreed to sub-market pay until the share price hits 35 cents, signaling strong alignment with shareholder interests.

NeuroScientific Biopharmaceuticals has appointed Nathan Smith as CEO, leveraging his deep cell therapy expertise to accelerate clinical development and commercialisation of its StemSmart technology.

Tamboran Resources appoints Chairman Dick Stoneburner as interim CEO following Joel Riddle’s departure, while adding two seasoned energy executives to its board as it advances gas production plans in the Beetaloo Basin.